BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23063973)

  • 1. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
    Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
    Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a C-type CpG ODN on CVB3-infected mice].
    Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
    Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P
    Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
    J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.
    Fengqin L; Yulin W; Xiaoxin Z; Youpeng J; Yan C; Qing-qing W; Hong C; Jia S; Lei H
    J Ethnopharmacol; 2010 Feb; 127(2):221-8. PubMed ID: 19932162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.
    Li Z; Yue Y; Xiong S
    Cardiovasc Pathol; 2013; 22(5):373-82. PubMed ID: 23523188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.
    Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J
    Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression.
    Chen J; Wang Z; Wu T
    Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1826-34. PubMed ID: 23374452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
    Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
    Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
    Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
    Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.